calendar
2,377 catalysts · 4,779 phase readout · 2,366 8k filing · 285 earnings · 271 pdufa · 172 phase 2 completion · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
2,377 catalysts · 4,779 phase readout · 2,366 8k filing · 285 earnings · 271 pdufa · 172 phase 2 completion · 73 phase 1 completion
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Items: 1.01, 7.01, 9.01
Items: 1.01, 9.01
Items: 3.01
Items: 5.02
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.01, 9.01
Items: 8.01, 9.01
Items: 5.02
Items: 5.02, 9.01
Items: 1.01, 8.01, 9.01
Items: 5.02
Items: 5.02
Items: 1.01, 2.01, 3.02, 9.01
Items: 9.01
Items: 5.07
Items: 1.01, 8.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.01, 9.01
Items: 5.03, 9.01
Items: 1.01, 9.01
Items: 5.02, 9.01
Items: 2.03
Items: 7.01, 8.01, 9.01
Items: 2.04
Items: 8.01, 9.01
Items: 1.01, 5.02, 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 2.02, 5.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 8.01
Items: 1.01, 8.01, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 1.01, 2.01, 2.03, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01